Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Gates Foundation

America: To evaluate novel TB drug combinations in the in vitro hollow fiber system for TB to inform our understanding of efficacy and dose selection

Last update: Apr 9, 2026 Last update: Apr 9, 2026

Details

Locations:USA
Start Date:Feb, 2021
End Date:May, 2022
Contract value: USD 631,733
Sectors:Health, Monitoring & Evaluation
 Health, Monitoring & Evaluation
Categories:Grants
Funding Agencies:
Gates Foundation
Date posted:Apr 9, 2026
Contracting authority:Gates Foundation

Associated funding

Associated experts

Description

Purpose: To evaluate novel TB drug combinations in the in vitro hollow fiber system for TB to inform our understanding of efficacy and dose selection
Division: Global Health
Region served: AMERICA
Grant topic: Tuberculosis
Duration (months): 15
Grantee location: Dallas, Texas, United States
Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.
Learn more about our membership benefits
Print